Grifols | GRFS - Betriebsaufwand

Aktienkurs
8.08
Täglich Wechseln
0.09 1.13%
Monatlich
4.80%
Jährlich
12.07%
Q2 Prognose
7.87




Betriebsaufwand Veränderung Datum
Alaunos Therapeutics USD 1.19M 148K 2025-09
Arca Biopharma USD 34.43M 326K 2025-12
aTyr Pharma USD 85.61M 58.67M 2025-12
Bio Path USD 488K 4.07M 2025-09
Brainstorm Cell Therapeutics USD 2.24M 197K 2025-12
Capricor Therapeutics USD 29.16M 2.87M 2025-12
Cara Therapeutics USD 5.94M 983K 2025-09
Esperion Therapeutics USD 83.21M 14.06M 2025-12
GlaxoSmithKline GBP 7.18B 1.42B 2025-12
Grifols EUR 1.99B 217.4M 2025-12
Immunic USD 25.73M 2.91M 2024-09
Infinity Pharmaceuticals USD 10.7M 1.54M 2023-06
Minerva Neurosciences USD 4.52M 155.46K 2024-12
Nektar Therapeutics USD 40.9M 44.19M 2025-12
Sangamo BioSciences USD 33.87M 12.89M 2024-06
TherapeuticsMD USD 1.41M 50K 2024-06